XHKG
8372
Market cap14mUSD
Jul 08, Last price
0.14HKD
1Q
8.59%
IPO
-57.88%
Name
Grand Brilliance Group Holdings Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Grand Brilliance Group Holdings Limited, an investment holding entity, primarily operates by distributing medical equipment and related items across Hong Kong. Its extensive product portfolio encompasses various medical supplies, including disposables, specialized instruments, and advanced medical machinery. The company also undertakes the development of innovative healthcare products. Beyond product distribution, it delivers comprehensive medical device solutions such as in-depth market trend assessments, strategic sourcing, post-sale support, technical training, equipment rental, and stringent quality assurance. Additionally, the firm manages maintenance services and holds several registered trademarks. Its diverse client base spans both public and private healthcare facilities, independent clinics, charitable groups, academic institutions, and direct consumers. Established in 1997, the company is headquartered in Tsuen Wan, Hong Kong, and operates as a subsidiary of B&A Success Limited.
IPO date
Mar 29, 2018
Employees
41
Domiciled in
HK
Incorporated in
KY
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||